Consensus Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-12-16 EST			5-day change	1st Jan Change
4,518.00 ^JPY	+0.83%		+1.32%	+8.06%

09:34am	Takeda Canada: British Columbia reimburses Fruzaqla for treatment of metastatic colorectal cancer	RE
12-07	Takeda, Protagonist Report One-Year Rusfertide Gains in PV trial	MT

Evolution of the Average Target: Takeda Pharmaceutical Company Limited

Evolution of the Target Price: Takeda Pharmaceutical Company Limited

Changes in Analyst Recommendations: Takeda Pharmaceutical Company Limited

2d32.4-QcjzAiEfbzMlZjhAGTjQGtoBXd5nY03Xvci7y7g54.msl__kMTfMKmRhwPyE_ftWbn13KplU967AK01OTUtq-L1U6-c1FUmKl1NQ~39a2e7d503aec7ab94f0ec64ac16a8cf

Analysts' recommendations: Takeda Pharmaceutical Company Limited

11-11	Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study	MT
09-26	Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says	MT
08-20	Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says	MT
05-09	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	MT
05-06	Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	MT
24-08-12	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	MT
24-07-31	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	MT
24-02-13	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	MT
23-10-03	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	MT
23-09-22	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	MT
23-05-31	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	MT
23-05-16	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	MT
23-04-04	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	MT
23-03-23	Japanese shares hover near session high on hints of Fed rate pause	RE
23-03-16	BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	MT
23-03-06	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	MT
22-08-01	Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	MT
22-07-19	Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	MT
21-10-07	TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	MT
21-05-31	Takeda Pharmaceutical : Japanese shares inch down as investors await key U.S. economic data	RE
17-09-08	BAYER : Germany's Merck hires JP Morgan to sell consumer health	RE

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TAKEDA PHARMACEUTICAL COMPANY LIMITED					+10.38%
	ELI LILLY AND COMPANY					+1.21%
	JOHNSON & JOHNSON					-3%
	ABBVIE INC.					+7.4%
	ROCHE HOLDING AG					+0.43%
	ASTRAZENECA PLC					+10.56%
	NOVARTIS AG					+0.39%
	MERCK & CO., INC.					+7.76%
	NOVO NORDISK A/S					+24.3%
	AMGEN INC.					+0.18%
	Average					+5.96%
	Weighted average by Cap.					+3.95%